<code id='90993AA0EF'></code><style id='90993AA0EF'></style>
    • <acronym id='90993AA0EF'></acronym>
      <center id='90993AA0EF'><center id='90993AA0EF'><tfoot id='90993AA0EF'></tfoot></center><abbr id='90993AA0EF'><dir id='90993AA0EF'><tfoot id='90993AA0EF'></tfoot><noframes id='90993AA0EF'>

    • <optgroup id='90993AA0EF'><strike id='90993AA0EF'><sup id='90993AA0EF'></sup></strike><code id='90993AA0EF'></code></optgroup>
        1. <b id='90993AA0EF'><label id='90993AA0EF'><select id='90993AA0EF'><dt id='90993AA0EF'><span id='90993AA0EF'></span></dt></select></label></b><u id='90993AA0EF'></u>
          <i id='90993AA0EF'><strike id='90993AA0EF'><tt id='90993AA0EF'><pre id='90993AA0EF'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:explore    Page View:7
          Black and white illustrated portrait of Mark Parrino
          Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

          Nobody has made more of an impact on methadone treatment than Mark Parrino.

          For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

          advertisement

          Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Drug for rare kidney disease narrowly misses mark in clinical trial
          Drug for rare kidney disease narrowly misses mark in clinical trial

          AdobeTravereTherapeuticssaidThursdaythatastudymeanttoconfirmthebenefitofitsnewlyapproveddrugforarare

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Why are Kaiser Permanente staff considering a strike?

          Morethan75,000KaiserPermanentehealthcareworkershavevotedtoauthorizeastrikeifthetwosidescan'treachade